CYP2A7 Polyclonal Antibody

CYP2A7 encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum; its substrate has not yet been determined. CYP2A7, which produces two transcript variants, is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q.

The CYP2A7 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of CYP2A7 protein expression in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional performance and reliability.

With its polyclonal nature, this antibody exhibits a broad reactivity towards CYP2A7, enabling it to recognize multiple epitopes on the target protein. This characteristic enhances the antibody's versatility and suitability for a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The CYP2A7 Polyclonal Antibody demonstrates exceptional sensitivity, allowing for the detection of even low levels of CYP2A7 protein expression. Its high specificity ensures minimal cross-reactivity with other related proteins, thereby providing accurate and reliable results.

This antibody has been rigorously validated using various experimental approaches, ensuring its consistent performance across different sample types and experimental conditions. Its robustness and reproducibility make it an ideal choice for researchers and scientists working in the fields of drug metabolism, toxicology, and pharmacology.

Furthermore, the CYP2A7 Polyclonal Antibody is manufactured under stringent quality control standards, guaranteeing its purity, stability, and batch-to-batch consistency. It is supplied in a convenient format, allowing for easy storage and handling.

In summary, the CYP2A7 Polyclonal Antibody is a highly reliable and specific tool for the detection and quantification of CYP2A7 protein expression. Its exceptional sensitivity, versatility, and rigorous validation make it an indispensable asset for researchers seeking to explore the role of CYP2A7 in various biological processes.